Gelesis rounds up $3.6M in fresh venture funds

Gelesis, a biotech startup focused on developing new obesity treatments, has raised $3.6 million, reports Globes. The new money brings its total take to date to $20 million. Gelesis was one of FierceBiotech's Fierce 15 in 2010. Story